Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, GSK asthma inhalers, and more

    by Ed Silverman Mar 21, 2024 1 minute
    Source: Alex Hogan/STAT

    Top of the morning to you, and a fine one it is. Although quite chilly so far, the clear, blue skies and warm sunshine are a heartening elixir for a busy day ahead. about weight-loss drugs. To cope, we are brewing fresh cups of stimulation. Our choice today is orange creme. As always you are invited to join us. Meanwhile, here are a few items of interest to get you started on your own journey, which we hope will be informative and exciting. Keep in touch, everyone….

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks